T he fungal kingdom encompasses Ϸ1.5 million species (1) as diverse as single-celled yeasts, pathogens of animals/plants, and plant root symbionts. Fungi are eukaryotic, closely aligned with metazoans (2, 3) . Animals and fungi diverged Ϸ1 billion years ago; their last common ancestor was unicellular, motile, and aquatic. Some fungi grow as unicellular yeasts, but most are filamentous multicellular organisms. Importantly, some fungi are dimorphic, growing as both yeast and filamentous forms (i.e., Saccharomyces cerevisiae). Yet others are trimorphic and grow as yeast, hyphae, and pseudohyphae (i.e., Candida albicans). S. cerevisiae pseudohyphal growth long eluded detection-it requires special conditions/strains and was lost during domestication (4) . How pseudohyphae are related to yeast and hyphae (as a distinct fate or a continuum) was unknown until the report of Carlisle et al. (5) in this issue of PNAS. They reveal that pseudohyphae are intermediate between yeast and hyphae, with implications for pathogen-host interactions and fungal evolution.
C. albicans is a trimorphic fungus from the Ascomycota, diverged from S. cerevisiae Ϸ200 million years ago (6, 7) , and a commensal of the human microbiota of the gastrointestinal tract, mucous membranes, and skin. C. albicans infects humans, causing oropharyngeal disease, vaginitis, and systemic life-threatening infection. Serum induces C. albicans yeast to produce germ tubes, and growth in defined media elicits two filamentous growth modes: pseudohyphae and hyphae (Fig. 1A) . Pseudohyphae resemble hyphae, but are morphologically distinct. In both modes the normally ovoid yeast cells are elongated, but in pseudohyphae each cell-cell junction is constricted, and the diameter between cell walls is wider in the middle than the ends. In contrast, hyphal cell walls are parallel with no mother-daughter or septal junction constrictions. Pseudohyphae and hyphae also differ with respect to septin localization and nuclear division (7) . Given these differences, it has been unclear whether pseudohyphae are an intermediate between yeast and hyphae or are an alternative fate (Fig. 1 ). This question, and implications for virulence, were addressed by Carlisle et al. with engineered strains (5) .
The C. albicans dimorphic yeast-hyphae transition is thought to underlie its success as a pathogen. Mutants locked as yeasts (lacking Cph1 and Efg1 transcription factors or cyclin Hgc1) or filaments (lacking the Tup1 repressor) are both avirulent, linking both forms to pathogenesis (8) (9) (10) . Subsequently, a strain was engineered in which morphogenesis is controlled by regulated expression of a filamentation repressor, Nrg1, with the tet promoter (11) . Cells grown without doxycycline express Nrg1 and grow as yeast, whereas growth with doxycycline repressed Nrg1 and filamentous growth ensued. Animals infected with yeast remained healthy yet harbored a significant latent fungal burden in the kidney. Adding doxycycline to drinking water activated filamentation, with progression to lethal infection. These studies provide robust support for the concept that dimorphic transitions underlie C. albicans virulence, and they show that yeast can penetrate tissues, whereas hyphae are necessary for progression to lethal infection. In cultured macrophages S. cerevisiae is killed after phagocytosis, whereas C. albicans yeast switch to hyphae, killing and escaping macrophages (12) .
The studies of Carlisle et al. (5) involve controlling expression of Ume6, a zinc-finger transcription factor downstream of Nrg1 in circuits for dimorphic transition and virulence (13, 14) . In their studies, Ume6 was expressed from the doxycycline-regulatable promoter (tet-UME6), leading to controlled consequences: yeast with the promoter off (doxϩ), and hyphae in response to high-level Ume6 (doxϪ), even under non-filamentinducing conditions. Intermediate expression elicited a third fate: pseudohyphae. Increasing Ume6 levels converted pseudohyphae to hyphae, and hybrid hyphal/pseudohyphal filaments were observed. When the tet-UME6 strain was grown as hyphae (doxϪ) and then shifted to repress (doxϩ), filaments produced a majority of pseudohyphae by 3 h and yeast by 7 h. Thus both filamentous modes can be reversibly evoked by expressing a single regulatory element in a dosagedependent fashion, providing evidence that pseudohyphae are intermediate between yeast and hyphae, rather than a distinct fate. When animals were infected with yeast of the tet-UME6 strain (doxϪ), increased Ume6 expression led to enhanced hyphal growth and tissue invasion and more rapid demise; animals given doxycycline survived much longer. Hence, hyphal growth (or hyphalspecific gene expression) promotes C. albicans virulence.
The findings of Carlisle et al. (5) have broad implications for dimorphism in fungal pathogenesis (Fig. 2) . S. cerevisiae and C. albicans both undergo yeast-pseudohyphal transitions, but only C. albicans develops hyphae. As C. albicans evolved into a successful commensal of the mammalian gastrointestinal tract, formation of hyphae in biofilms was likely necessary to compete with bacteria, or to form cooperative multispecies biofilms (15) . Hyphae are also critical for C. albicans to survive and escape host macrophages. As a result, the trimorphic species C. albicans is a successful commensal and pathogen, whereas the dimorphic yeast S. cerevisiae is an uncommon pathogen (16) . Exploring genetic circuits controlling dimorphism in both species, and those between them, is likely to be illustrative.
The ability of fungi to infect humans occurred independently multiple times, and successful human pathogens are diverse (Fig.  2) . The prominent role for hyphae in C. albicans virulence is contrasted with a leading role for yeast in other pathogens. The dimorphic fungal pathogens (i.e., Histoplasma capsulatum) are thermally dimorphic, growing as filamentous molds at lower environmental temperatures and as yeast at 37°C (17) . Humans are infected by inhaled conidia that must convert to yeast to be pathogenic. Strains or mutants locked as filaments are avirulent (18, 19) . In the Basidiomycota phylum, the plant pathogen Ustilago maydis can grow as yeast, but successful plant infection requires filamentous dikaryons produced by mating (20) . The human pathogen Cryptococcus neoformans undergoes a similar sexual dimorphic transition, but spores or dried yeast cells infect humans and only yeast occur in the host (21) . Other fungi infecting plants and humans are strictly filamentous. How these diverse pathogenic strategies subvert host defenses may share common principles, or converge via distinct mechanisms.
The findings of Carlisle et al. (5) have broader evolutionary implications. The finding that pseudohyphae are a developmental way station between yeast and hyphae suggests stepwise evolution (Fig. 1B) . We can envision an ancestral fungus as a unicellular yeast making the leap, first to pseudohyphae and then hyphae. This would have facilitated foraging for mating partners and nutrients and rapid colonization of habitats, including plants/animals. In this model mutations may block just hyphal growth, or hyphal and pseudohyphal growth. Overexpression of other regulatory components may enable dimorphic yeasts to produce hyphae. Most fungi are filamentous with no yeast form, thus mutations preventing the dimorphic return to yeast likely confer selective benefits. These studies may provide insights into how closely related species evolved divergent life styles (Fig. 2) . S. cerevisiae grows as yeast and pseudohyphae but not hyphae, whereas its close relative Ashbya gossypii grows only as hyphae and Holleya sinecauda grows as yeast, pseudohyphae, and hyphae (22) (23) (24) . A. gossypii thus lacks functions for hyphal-yeast transition, and H. sinecauda has factors enabling hyphal growth from yeast and pseudohyphae. Recent studies reveal that the pescadillo ortholog promotes production of budding yeast cells from C. albicans hyphae (25) , and related factors may enable Cryptococcus neoformans hyphae to produce yeast cells (21) . Other fungi, such as Mucor sp. in the Zygomycota, prominently grow as filamentous fungi in lab aerobic conditions yet also grow as multibudded yeasts in anaerobic/high-CO 2 conditions (26) . Conditions or mutations enabling other filamentous fungi to grow as pseudohyphae or yeast may remain to be discovered. Understanding genetic circuits evoking transitions in fungal form, and impact on biology and infection, will continue to fascinate for years to come.
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